Add to my calendar2022-09-09 15:00:002022-09-09 17:15:00Multi-therapeutic Half Day
This program was made possible through educational support from Pfizer Canada.
Speaker(s)
Dr. Andrew Shih, MD, FRCPC, DRCPSC, MSc
Dr. Kevin McLeod, RCPSC, Internal Medicine
Dr. Liam Brunham, MD, PhD, FRCPC, FACP, FNLA
Moderator: Dr. Walter Chow, BSc (Pharm)
Learning objectives:
Iron deficiency anemia update in BC
Recall the diagnostic assessment and investigational tests used for iron deficiency anemia (IDA).
Implement the management algorithm of IDA to achieve optimal patient outcomes.
Identify the main clinical indications for currently available IV iron therapies and recognize their differences through evidence-based research.
COVID-19 Therapeutics Update
Explain the COVID-19 landscape and disease burden in Canada.
Explain the mechanism of action, efficacy, and safety of outpatient therapies.
Apply national and provincial guidelines for the treatment of COVID-19 outpatients.
Identify patients eligible for outpatient therapies based on risk stratification.
Describe the role of primary care in the treatment of COVID-19 outpatients
Icosapent Ethyl in Cardiovascular Disease: Knowledge Translation of the New Dyslipidemia Guidelines
Recognize that persistent CV risk (PCVR) remains in statin treated patients.
Identify elevated triglycerides as a marker of persistent CV risk.
Review the evidence for CV event reduction in statin-treated patients with elevated triglycerides.
Describe a recent non-statin therapy for CV event reduction in statin-treated patients with elevated TGs.
Apply novel cardiovascular risk management therapies to statin-treated patients with PCVR.
How to join:
Registration required
For more information please contact colin.williams@pfizer.com or call 1-604-619-4869.
CME: This learning program is not accredited.
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.
Online Event
Physician Educationphysician.education@northernhealth.caAmerica/Vancouverpublic
Add to Calendar: Start date2022-09-09 15:00:002024-05-16 21:26:24TitleDescriptionLocationPhysiciansrajbir.singh@opin.caAmerica/Vancouverpublic
Add to Calendar: End Date2024-05-16 21:26:242022-09-09 17:15:00Multi-therapeutic Half Day
Please join us virtually for a compelling education day.
Online Event
Physiciansrajbir.singh@opin.caAmerica/Vancouverpublic
This program was made possible through educational support from Pfizer Canada.
Speaker(s)
Dr. Andrew Shih, MD, FRCPC, DRCPSC, MSc
Dr. Kevin McLeod, RCPSC, Internal Medicine
Dr. Liam Brunham, MD, PhD, FRCPC, FACP, FNLA
Moderator: Dr. Walter Chow, BSc (Pharm)
Learning objectives:
Iron deficiency anemia update in BC
Recall the diagnostic assessment and investigational tests used for iron deficiency anemia (IDA).
Implement the management algorithm of IDA to achieve optimal patient outcomes.
Identify the main clinical indications for currently available IV iron therapies and recognize their differences through evidence-based research.
COVID-19 Therapeutics Update
Explain the COVID-19 landscape and disease burden in Canada.
Explain the mechanism of action, efficacy, and safety of outpatient therapies.
Apply national and provincial guidelines for the treatment of COVID-19 outpatients.
Identify patients eligible for outpatient therapies based on risk stratification.
Describe the role of primary care in the treatment of COVID-19 outpatients
Icosapent Ethyl in Cardiovascular Disease: Knowledge Translation of the New Dyslipidemia Guidelines
Recognize that persistent CV risk (PCVR) remains in statin treated patients.
Identify elevated triglycerides as a marker of persistent CV risk.
Review the evidence for CV event reduction in statin-treated patients with elevated triglycerides.
Describe a recent non-statin therapy for CV event reduction in statin-treated patients with elevated TGs.
Apply novel cardiovascular risk management therapies to statin-treated patients with PCVR.
Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.